MD HB676 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 17-9)
Status: Passed on May 16 2024 - 100% progression
Action: 2024-05-16 - Approved by the Governor - Chapter 960
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Slight Partisan Bill (Democrat 17-9)
Status: Passed on May 16 2024 - 100% progression
Action: 2024-05-16 - Approved by the Governor - Chapter 960
Text: Latest bill text (Chaptered) [PDF]
Summary
Altering certain provisions of law authorizing certain activity by manufacturers of investigational drugs, biological products, or devices under the Right to Try Act to apply to manufacturers of certain individualized investigational treatments; altering the definition of "eligible patient" under the Right to Try Act to include individuals who have life-threatening or severely debilitating illnesses, rather than only individuals who have terminal illnesses; etc.
Title
Right to Try Act - Individualized Investigational Treatments
Sponsors
Roll Calls
2024-04-04 - Senate - Third Reading Passed (Y: 47 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-13 - House - Third Reading Passed (Y: 137 N: 0 NV: 0 Abs: 4) [PASS]
2024-03-13 - House - Third Reading Passed (Y: 137 N: 0 NV: 0 Abs: 4) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-16 | House | Approved by the Governor - Chapter 960 |
| 2024-04-04 | House | Returned Passed |
| 2024-04-04 | Senate | Third Reading Passed (47-0) |
| 2024-04-02 | Senate | Second Reading Passed |
| 2024-04-02 | Senate | Favorable Adopted |
| 2024-04-01 | Senate | Favorable Report by Finance |
| 2024-03-15 | Senate | Hearing 3/21 at 1:00 p.m. |
| 2024-03-14 | Senate | Referred Finance |
| 2024-03-13 | House | Third Reading Passed (137-0) |
| 2024-03-12 | House | Second Reading Passed with Amendments |
| 2024-03-12 | House | Favorable with Amendments {493123/1 Adopted |
| 2024-03-11 | House | Favorable with Amendments Report by Health and Government Operations |
| 2024-02-09 | House | Hearing 2/29 at 1:00 p.m. |
| 2024-01-25 | House | First Reading Health and Government Operations |
Subjects
Administrative Agencies
Attorney General
Committees and Commissions
Consumer Protection
Drugs
Equipment
Genetics
Health
Health Care Facilities
Health Insurance
Health Occupations
Health, Department of
Hospices
Hospitals
Immunization
Industry and Technology
Medical Assistance
Medical Conditions
Medical Testing and Diagnosis
Medical Treatments
Patients
Physicians
Prices
Privacy
Public Health
Records
Revenue and Taxes
Attorney General
Committees and Commissions
Consumer Protection
Drugs
Equipment
Genetics
Health
Health Care Facilities
Health Insurance
Health Occupations
Health, Department of
Hospices
Hospitals
Immunization
Industry and Technology
Medical Assistance
Medical Conditions
Medical Testing and Diagnosis
Medical Treatments
Patients
Physicians
Prices
Privacy
Public Health
Records
Revenue and Taxes
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| Health - General | 21-2B | 01 | (n/a) | See Bill Text |
| Health - General | 21-2B | 2 | (n/a) | See Bill Text |
| Health - General | 21-2B | 3 | (n/a) | See Bill Text |
| Health - General | 21-2B | 4 | (n/a) | See Bill Text |
| Health - General | 21-2B | 5 | (n/a) | See Bill Text |
| Health - General | 21-2B | 6 | (n/a) | See Bill Text |
